Bionano Genomics (MEX:BNGO) EV-to-Revenue : 0.43 (As of Jun. 01, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Bionano Genomics EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Bionano Genomics's enterprise value is MXN242.2 Mil. Bionano Genomics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was MXN564.3 Mil. Therefore, Bionano Genomics's EV-to-Revenue for today is 0.43.

The historical rank and industry rank for Bionano Genomics's EV-to-Revenue or its related term are showing as below:

MEX:BNGO' s EV-to-Revenue Range Over the Past 10 Years
Min: -4.93 Med: 2.9 Max: 303.81
Current: 0.44

During the past 9 years, the highest EV-to-Revenue of Bionano Genomics was 303.81. The lowest was -4.93. And the median was 2.90.

MEX:BNGO's EV-to-Revenue is ranked better than
94.3% of 824 companies
in the Medical Devices & Instruments industry
Industry Median: 3.09 vs MEX:BNGO: 0.44

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-01), Bionano Genomics's stock price is MXN71.70. Bionano Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was MXN2,236.41. Therefore, Bionano Genomics's PS Ratio for today is 0.03.

Bionano Genomics EV-to-Revenue Historical Data

The historical data trend for Bionano Genomics's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionano Genomics EV-to-Revenue Chart

Bionano Genomics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EV-to-Revenue

Get a 7-Day Free Trial

66.29

34.85

11.95

0.81

0.97

Bionano Genomics Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EV-to-Revenue	Get a 7-Day Free Trial															1.31	1.55	1.19	0.97	0.31

Competitive Comparison of Bionano Genomics's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Bionano Genomics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionano Genomics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionano Genomics's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bionano Genomics's EV-to-Revenue falls into.

Save Embed

;

Save Embed

;

Bionano Genomics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Bionano Genomics's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	242.204	/	564.289
	=	0.43

Bionano Genomics's current Enterprise Value is MXN242.2 Mil.
Bionano Genomics's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN564.3 Mil.

Bionano Genomics (MEX:BNGO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Bionano Genomics's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	71.70	/	2236.412
	=	0.03

Bionano Genomics's share price for today is MXN71.70.
Bionano Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN2,236.41.

Bionano Genomics EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bionano Genomics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionano Genomics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bionano Genomics Inc (MEX:BNGO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

BNGO:USA

Address

9540 Towne Centre Drive, Suite 100, San Diego, CA, USA, 92121

Website

https://www.bionano.com

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.